Literature DB >> 35229216

Synthesis and antimalarial activity of amide and ester conjugates of siderophores and ozonides.

Rohit Tiwari1, Lisa Checkley2, Michael T Ferdig2, Jonathan L Vennerstrom3, Marvin J Miller4.   

Abstract

Despite advances in chemotherapeutic interventions for the treatment of malaria, there is a continuing need for the development of new antimalarial agents. Previous studies indicated that co-administration of chloroquine with antioxidants such as the iron chelator deferoxamine (DFO) prevented the development of persistent cognitive damage in surrogate models of cerebral malaria. The work described herein reports the syntheses and antimalarial activities of covalent conjugates of both natural (siderophores) and artificial iron chelators, namely DFO, ferricrocin and ICL-670, with antimalarial 1,2,4-trioxolanes (ozonides). All of the synthesized conjugates had potent antimalarial activities against the in vitro cultures of drug resistant and drug sensitive strains of Plasmodium falciparum. The work described herein provides the basis for future development of covalent combination of iron chelators and antimalarial chemotherapeutic agents for the treatment of cerebral malaria.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Antimalarials; Cerebral malaria; Iron chelation; Siderophore-ozonide conjugates

Year:  2022        PMID: 35229216      PMCID: PMC9433463          DOI: 10.1007/s10534-022-00375-8

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   3.378


  22 in total

1.  Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.

Authors:  Renzo Galanello; Antonio Piga; Daniele Alberti; Marie-Claude Rouan; Hilde Bigler; Romain Séchaud
Journal:  J Clin Pharmacol       Date:  2003-06       Impact factor: 3.126

2.  Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate.

Authors:  C J Drakeley; M T Duraisingh; M Póvoa; D J Conway; G A Targett; D A Baker
Journal:  Mol Biochem Parasitol       Date:  1996-10-30       Impact factor: 1.759

Review 3.  Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.

Authors:  Devdutt Chaturvedi; Abhishek Goswami; Partha Pratim Saikia; Nabin C Barua; Paruchuri G Rao
Journal:  Chem Soc Rev       Date:  2009-08-24       Impact factor: 54.564

Review 4.  Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds.

Authors:  Kristina Borstnik; Ik-hyeon Paik; Theresa A Shapiro; Gary H Posner
Journal:  Int J Parasitol       Date:  2002-12-04       Impact factor: 3.981

5.  Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum.

Authors:  B Pradines; J M Rolain; F Ramiandrasoa; T Fusai; J Mosnier; C Rogier; W Daries; E Baret; G Kunesch; J Le Bras; D Parzy
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

Review 6.  Iron chelating agents for treating malaria.

Authors:  H J Smith; M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2003

7.  A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains.

Authors:  Mark D Preston; Susana Campino; Samuel A Assefa; Diego F Echeverry; Harold Ocholla; Alfred Amambua-Ngwa; Lindsay B Stewart; David J Conway; Steffen Borrmann; Pascal Michon; Issaka Zongo; Jean-Bosco Ouédraogo; Abdoulaye A Djimde; Ogobara K Doumbo; Francois Nosten; Arnab Pain; Teun Bousema; Chris J Drakeley; Rick M Fairhurst; Colin J Sutherland; Cally Roper; Taane G Clark
Journal:  Nat Commun       Date:  2014-06-13       Impact factor: 14.919

Review 8.  Oxidative stress in malaria.

Authors:  Sandro Percário; Danilo R Moreira; Bruno A Q Gomes; Michelli E S Ferreira; Ana Carolina M Gonçalves; Paula S O C Laurindo; Thyago C Vilhena; Maria F Dolabela; Michael D Green
Journal:  Int J Mol Sci       Date:  2012-12-03       Impact factor: 5.923

9.  Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439.

Authors:  David M Shackleford; Francis C K Chiu; Kasiram Katneni; Scott Blundell; Jenna McLaren; Xiaofang Wang; Lin Zhou; Kamaraj Sriraghavan; André M Alker; Daniel Hunziker; Christian Scheurer; Qingjie Zhao; Yuxiang Dong; Jörg J Möhrle; Nada Abla; Hugues Matile; Sergio Wittlin; Jonathan L Vennerstrom; Susan A Charman
Journal:  ACS Infect Dis       Date:  2021-06-08       Impact factor: 5.578

Review 10.  Antimalarial drug discovery - the path towards eradication.

Authors:  Jeremy N Burrows; Emilie Burlot; Brice Campo; Stephanie Cherbuin; Sarah Jeanneret; Didier Leroy; Thomas Spangenberg; David Waterson; Timothy Nc Wells; Paul Willis
Journal:  Parasitology       Date:  2013-07-17       Impact factor: 3.234

View more
  1 in total

Review 1.  Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.

Authors:  Antonio Rafael Quadros Gomes; Natasha Cunha; Everton Luiz Pompeu Varela; Heliton Patrick Cordovil Brígido; Valdicley Vieira Vale; Maria Fâni Dolabela; Eliete Pereira De Carvalho; Sandro Percário
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.